Skip to main content
Erschienen in: Inflammopharmacology 6/2023

13.10.2023 | Commentary

Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments

verfasst von: Salvatore Chirumbolo, Sergio Pandolfi, Marianno Franzini, Luigi Valdenassi

Erschienen in: Inflammopharmacology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

A comment to: Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG. Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. 2023 Jul 12. https://​doi.​org/​10.​1007/​s10787-023-01288-9.
Literatur
Zurück zum Zitat Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, Albini A (2023) The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol 8(14):1161067 CrossRef Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, Albini A (2023) The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol 8(14):1161067 CrossRef
Zurück zum Zitat Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, Pandolfi S (2021) Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol 96:107777 CrossRefPubMedPubMedCentral Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, Pandolfi S (2021) Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol 96:107777 CrossRefPubMedPubMedCentral
Zurück zum Zitat Fernández-Cuadros ME, Albaladejo-Florín MJ, Peña-Lora D, Álava-Rabasa S, Pérez-Moro OS (2020) Ozone (O3) and SARS-CoV-2: Physiological bases and their therapeutic possibilities according to COVID-19 evolutionary stage. SN Compr Clin Med 2(8):1094–1102 CrossRefPubMedPubMedCentral Fernández-Cuadros ME, Albaladejo-Florín MJ, Peña-Lora D, Álava-Rabasa S, Pérez-Moro OS (2020) Ozone (O3) and SARS-CoV-2: Physiological bases and their therapeutic possibilities according to COVID-19 evolutionary stage. SN Compr Clin Med 2(8):1094–1102 CrossRefPubMedPubMedCentral
Zurück zum Zitat Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, Tirelli U (2020) Oxygen-ozone (O 2–O 3) immunoceutical therapy for patients with COVID-19. Preliminary Evidence Reported Int Immunopharmacol 88:106879 CrossRefPubMed Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, Tirelli U (2020) Oxygen-ozone (O 2–O 3) immunoceutical therapy for patients with COVID-19. Preliminary Evidence Reported Int Immunopharmacol 88:106879 CrossRefPubMed
Zurück zum Zitat Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG (2023) Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. https://​doi.​org/​10.​1007/​s10787-023-01288-9 CrossRefPubMed Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG (2023) Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. https://​doi.​org/​10.​1007/​s10787-023-01288-9 CrossRefPubMed
Zurück zum Zitat Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130 CrossRefPubMedPubMedCentral Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130 CrossRefPubMedPubMedCentral
Zurück zum Zitat Hernández A, Viñals M, Isidoro T, Vilás F (2020) Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia. Am J Case Rep 17(21):e925849 Hernández A, Viñals M, Isidoro T, Vilás F (2020) Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia. Am J Case Rep 17(21):e925849
Zurück zum Zitat Hsu CG, Chávez CL, Zhang C, Sowden M, Yan C, Berk BC (2022) The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis. Cell Death Differ 29(9):1790–1803 CrossRefPubMedPubMedCentral Hsu CG, Chávez CL, Zhang C, Sowden M, Yan C, Berk BC (2022) The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis. Cell Death Differ 29(9):1790–1803 CrossRefPubMedPubMedCentral
Zurück zum Zitat Islam H, Chamberlain TC, Mui AL, Little JP (2021) Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 21(12):677008 CrossRef Islam H, Chamberlain TC, Mui AL, Little JP (2021) Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action? Front Immunol 21(12):677008 CrossRef
Zurück zum Zitat Jafari-Oori M, Vahedian-Azimi A, Ghorbanzadeh K, Sepahvand E, Dehi M, Ebadi A, Izadi M (2022) Efficacy of ozone adjuvant therapy in COVID-19 patients: a meta-analysis study. Front Med (lausanne) 10(9):1037749 CrossRef Jafari-Oori M, Vahedian-Azimi A, Ghorbanzadeh K, Sepahvand E, Dehi M, Ebadi A, Izadi M (2022) Efficacy of ozone adjuvant therapy in COVID-19 patients: a meta-analysis study. Front Med (lausanne) 10(9):1037749 CrossRef
Zurück zum Zitat Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X (2021) Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 75(9):e14462 CrossRefPubMed Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X (2021) Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 75(9):e14462 CrossRefPubMed
Zurück zum Zitat Mousavizadeh L, Soltani R, Abedini K, Ghasemi S (2022) The relation of the viral structure of SARS-CoV-2, high-risk condition, and plasma levels of IL-4, IL-10, and IL-15 in COVID-19 patients compared to SARS and MERS infections. Curr Mol Med 22(7):584–593 CrossRefPubMed Mousavizadeh L, Soltani R, Abedini K, Ghasemi S (2022) The relation of the viral structure of SARS-CoV-2, high-risk condition, and plasma levels of IL-4, IL-10, and IL-15 in COVID-19 patients compared to SARS and MERS infections. Curr Mol Med 22(7):584–593 CrossRefPubMed
Zurück zum Zitat Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, Bichara CDA, Dos Santos EF, de Brito MTFM, da Silva ALS, Leite MM, da Costa FP, Viana MNDSA, Rodrigues FBB, de Sarges KML, Cantanhede MHD, da Silva R, Bichara CNC, van den Berg AVS, Veríssimo AOL, Carvalho MDS, Henriques DF, Dos Santos CP, Nunes JAL, Costa IB, Viana GMR, Carneiro FRO, Palacios VRDCM, Quaresma JAS, Brasil-Costa I, Dos Santos EJM, Falcão LFM, Vallinoto ACR (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422 CrossRefPubMedPubMedCentral Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, Bichara CDA, Dos Santos EF, de Brito MTFM, da Silva ALS, Leite MM, da Costa FP, Viana MNDSA, Rodrigues FBB, de Sarges KML, Cantanhede MHD, da Silva R, Bichara CNC, van den Berg AVS, Veríssimo AOL, Carvalho MDS, Henriques DF, Dos Santos CP, Nunes JAL, Costa IB, Viana GMR, Carneiro FRO, Palacios VRDCM, Quaresma JAS, Brasil-Costa I, Dos Santos EJM, Falcão LFM, Vallinoto ACR (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422 CrossRefPubMedPubMedCentral
Zurück zum Zitat Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22):5474 CrossRefPubMedPubMedCentral Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22):5474 CrossRefPubMedPubMedCentral
Zurück zum Zitat Torres M, Casado G, Vigón L, Rodríguez-Mora S, Mateos E, Ramos-Martín F, López-Wolf D, Sanz-Moreno J, Ryan-Murua P, Taboada-Martínez ML, López-Huertas MR, Cervero M, Coiras M (2022) Multidisciplinary Group of Study of COVID-19 (MGS-COVID); Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order). Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother 150:112965 CrossRefPubMedPubMedCentral Torres M, Casado G, Vigón L, Rodríguez-Mora S, Mateos E, Ramos-Martín F, López-Wolf D, Sanz-Moreno J, Ryan-Murua P, Taboada-Martínez ML, López-Huertas MR, Cervero M, Coiras M (2022) Multidisciplinary Group of Study of COVID-19 (MGS-COVID); Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order). Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother 150:112965 CrossRefPubMedPubMedCentral
Zurück zum Zitat Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U (2020) Potential mechanisms by which the oxygen-ozone (O2–O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci 24(8):4059–4061 PubMed Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U (2020) Potential mechanisms by which the oxygen-ozone (O2–O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci 24(8):4059–4061 PubMed
Zurück zum Zitat Wu J, Tan CS, Yu H, Wang Y, Tian Y, Shao W, Zhang Y, Zhang K, Shao H, Ni G, Shen J, Galoforo AC, Wu Q, Ming D (2020) Recovery of four COVID-19 patients via ozonated autohemotherapy. Innovation (camb) 1(3):100060 PubMed Wu J, Tan CS, Yu H, Wang Y, Tian Y, Shao W, Zhang Y, Zhang K, Shao H, Ni G, Shen J, Galoforo AC, Wu Q, Ming D (2020) Recovery of four COVID-19 patients via ozonated autohemotherapy. Innovation (camb) 1(3):100060 PubMed
Zurück zum Zitat Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, Xu B, Dai Y, Li X, Zhang C, Peng Y, Feng Y, Li A, Hu Z, Xiang H, Ogg G, Ho LP, McMichael A, Jin R, Knight JC, Dong T, Zhang Y (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5(13):e139834 CrossRefPubMedPubMedCentral Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, Xu B, Dai Y, Li X, Zhang C, Peng Y, Feng Y, Li A, Hu Z, Xiang H, Ogg G, Ho LP, McMichael A, Jin R, Knight JC, Dong T, Zhang Y (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5(13):e139834 CrossRefPubMedPubMedCentral
Zurück zum Zitat Zheng Z, Dong M, Hu K (2020) A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol 92(11):2348–2350 CrossRefPubMedPubMedCentral Zheng Z, Dong M, Hu K (2020) A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol 92(11):2348–2350 CrossRefPubMedPubMedCentral
Metadaten
Titel
Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments
verfasst von
Salvatore Chirumbolo
Sergio Pandolfi
Marianno Franzini
Luigi Valdenassi
Publikationsdatum
13.10.2023
Verlag
Springer International Publishing
Erschienen in
Inflammopharmacology / Ausgabe 6/2023
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-023-01359-x

Weitere Artikel der Ausgabe 6/2023

Inflammopharmacology 6/2023 Zur Ausgabe